Methods and compositions for the prevention and treatment of kidney disease

US9272033B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9272033-B2
Application numberUS-91208506-A
CountryUS
Kind codeB2
Filing dateApr 19, 2006
Priority dateApr 19, 2005
Publication dateMar 1, 2016
Grant dateMar 1, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides compositions for preventing or treating kidney disease comprising vitamin E, vitamin C, and a carotenoid and methods for preventing and treating kidney disease comprising administering such compositions to an animal susceptible to or suffering from kidney disease. In a preferred embodiment, the composition is admixed with one or more food ingredients to produce a food composition useful for preventing or treating kidney disease.

First claim

Opening claim text (preview).

What is claimed is: 1. A food composition comprising vitamin E, vitamin C, and a carotenoid in amounts sufficient for preventing or treating kidney disease, wherein the vitamin E is in an amount of from about 30 to about 1200 IU/kg, the vitamin C is in an amount of from about 0.01 to about 350 ppm vitamin C, and the carotenoid is in an amount from about 0.01 to about 3.5 ppm. 2. The composition of claim 1 comprising vitamin E, vitamin C, and a carotenoid in amounts sufficient to administer to a patient from at least 30 to 1200 IU/kg vitamin E, from at least 0.01 to 350 ppm vitamin C, and from at least 0.01 to 350 ppm carotenoid, wherein the patient is a canine or a feline. 3. The composition of claim 1 wherein the carotenoid is beta-carotene. 4. The composition of claim 1 further comprising one or more renal drugs. 5. The composition of claim 4 wherein the renal drug is selected from the group consisting of Converting Enzyme (ACE) inhibitors, androgens, erythropoietin, angiotensin, endothelin, angiotensin converting enzyme inhibitors, calcium channel blockers, H2 receptor antagonists, proton pump blockers, and calcitrol. 6. The composition of claim 1 further comprising one or more food ingredients. 7. The composition of claim 6 wherein the food ingredient is selected from the group consisting of fats, carbohydrates, proteins, fibers, and nutritional balancing agents. 8. The composition of claim 6 containing food ingredients in amounts from about 2% to about 50% fat, from about 0% to about 75% carbohydrate, from about 0% to about 95% protein, from about 0% to about 40% dietary fiber, and from about 0% to about 15% of one or more nutritional balancing agents. 9. The composition of claim 6 further comprising one or more renal drugs. 10. The composition of claim 9 wherein the renal drug is selected from the group consisting of Converting Enzyme (ACE) inhibitors, androgens, erythropoietin, angiotensin, endothelin, angiotensin converting enzyme inhibitors, calcium channel blockers, H2 receptor antagonists, proton pump blockers, and calcitrol.

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Free radical scavengers or antioxidants · CPC title

  • of the kidneys · CPC title

  • Organic substances · CPC title

  • Dry feed · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9272033B2 cover?
The invention provides compositions for preventing or treating kidney disease comprising vitamin E, vitamin C, and a carotenoid and methods for preventing and treating kidney disease comprising administering such compositions to an animal susceptible to or suffering from kidney disease. In a preferred embodiment, the composition is admixed with one or more food ingredients to produce a food com…
Who is the assignee on this patent?
Yu Shiguang, Allen Timothy Arthur, Hills Pet Nutrition Inc
What technology area does this patent fall under?
Primary CPC classification A61K45/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).